1 – 10 of 128
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2016
- The lung function profile of once-daily tiotropium and olodaterol via Respimat® is superior to that of twice-daily salmeterol and fluticasone propionate via Accuhaler® (ENERGITO® study)
- 2015
- Poliklinische rookstopinterventie bij rokers met comorbiditeiten
- Revalidatie voor longkankerpatiënten
- New developments in inhaler devices within pharmaceutical companies: a systematic review of the impact on clinical outcomes and patient preferences
- Evidence for autonomic function and its influencing factors in subjects with COPD: a systematic review
- Hot topics in noninvasive ventilation: report of a working group at the international symposium on sleep-disordered breathing in Leuven, Belgium
- Gecompenseerde metabole acidose op medicamenteuze basis
- Een 54-jarige vrouw met palpitaties en persisterende dyspneu in de subacute fase van een COPD-exacerbatie
- Activity of the alpha-1 antitrypsin deficiency registry in Belgium
- The 24-h lung-function profile of once-daily tiotropium and olodaterol fixed-dose combination in chronic obstructive pulmonary disease